La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Flora Growth Bilan de santé

Santé financière contrôle des critères 5/6

Flora Growth possède un total de capitaux propres de $8.3M et une dette totale de $2.4M, ce qui porte son ratio d'endettement à 29.2%. Son actif total et son passif total sont $30.1M et de $21.8M.

Informations clés

29.2%

Ratio d'endettement

US$2.42m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	US$6.13m
Fonds propres	US$8.27m
Total du passif	US$21.81m
Total des actifs	US$30.08m

Mises à jour récentes de la santé financière

Recent updates

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Sep 18

Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts

Aug 16

Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch

May 22

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Apr 04

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

Feb 17

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Dec 22

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Apr 17

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Dec 08

Flora Growth gains on deal to acquire No Cap Hemp assets

Sep 07

Elshad Garayev is the new finance chief of Flora Growth

Jul 11

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de FLGC ( $21.4M ) dépassent ses passifs à court terme ( $18.4M ).

Passif à long terme: Les actifs à court terme de FLGC ( $21.4M ) dépassent ses passifs à long terme ( $3.4M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: FLGC dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Données insuffisantes pour déterminer si le ratio d'endettement de FLGC a diminué au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: FLGC dispose d'une piste de trésorerie suffisante pour plus d'un an sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: FLGC devrait disposer d'une marge de trésorerie suffisante pour 12 mois sur la base des estimations de flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Flora Growth Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Flora Growth Announces Update on Compliance with the Audit Committee Composition Requirements of Nasdaq Listing Rule 5605(c)(2)(A)

Flora Growth Corp. Receives Non-Compliance Notice From NASDAQ

Flora Growth Regains Compliance with Nasdaq Minimum Bid Requirement

Recent updates

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More

Flora Growth Corp. Announces Board Changes

Flora Growth Announces Update on Compliance with the Audit Committee Composition Requirements of Nasdaq Listing Rule 5605(c)(2)(A)

Consensus revenue estimates fall by 12%

Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp. (NasdaqCM:FLGC) acquired Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV:LFST) for CAD 0.87 million.

Flora Growth Corp., Annual General Meeting, Aug 14, 2024

High number of new and inexperienced directors

Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch

Consensus EPS estimates upgraded to US$0.41 loss, revenue downgraded

Forecast to breakeven in 2025

First quarter 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Shareholder dilution

Flora Growth Corp. has filed a Follow-on Equity Offering.

Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story

Flora Growth Corp. has completed a Follow-on Equity Offering in the amount of $3.23 million.

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%

New major risk - Market cap size

The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More

Flora Growth Corp. Receives Non-Compliance Notice From NASDAQ

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Revenue and earnings growth

Flora Growth Corp. Announces the Resignation of Juan Carlos Roa Gomez as Director

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. announced that it expects to receive $2.738 million in funding

Flora Growth Corp. (NasdaqCM : FLGC) entered into a Sale and Purchase Agreement to acquire Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV : LFST) for $1.9 million.

Second quarter 2023 earnings: Revenues miss analyst expectations

Flora Growth Corp. Announces Resignation of Matthew Cohen as General Counsel

Flora Growth Corp. Appoints Dany Vaiman as Chief Financial Officer

Flora Growth Regains Compliance with Nasdaq Minimum Bid Requirement

Consensus EPS estimates upgraded to US$0.03 loss

Flora Growth Corp. Announces Board Appointments

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates upgraded to US$0.21 loss

Price target decreased by 24% to US$1.33

Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding

Price target increased by 18% to US$2.92

Flora Growth Corp Provides Revenue Guidance for the Year 2023

Flora Growth Corp. Announces Executive Changes

Price target decreased to US$2.12

Forecast to breakeven in 2024

News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts

Independent Director notifies of intention to sell stock

Third quarter 2022 earnings: EPS misses analyst expectations

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Price target decreased to US$2.67

High number of new and inexperienced directors

Flora Growth Corp. (NasdaqCM:FLGC) entered into a definitive agreement to acquire Franchise Global Health Inc. (TSXV:FGH) for CAD 32.2 million.

No longer forecast to breakeven

Flora Growth gains on deal to acquire No Cap Hemp assets

First half 2022 earnings released: US$0.42 loss per share (vs US$0.13 loss in 1H 2021)

Flora Growth Corp. Reaffirms Revenue Guidance for the Full Year 2022

Flora Growth Corp. to Report First Half, 2022 Results on Aug 15, 2022

High number of new and inexperienced directors

Flora Growth Appoints Elshad Garayev as Chief Financial Officer

Elshad Garayev is the new finance chief of Flora Growth

Flora Growth Corp. Announces Board Appointments

Flora Growth Corp. (NasdaqCM:FLGC) announces an Equity Buyback for $5 million worth of its shares.

Flora Growth Corp., Annual General Meeting, Jul 05, 2022

Flora Growth Corp. (NasdaqCM:FLGC) and Annabelle Manalo-Morgan agreed to acquire Masaya Medical, Inc.

Flora Growth Corp. Reiterates Earnings Guidance for the Full Year 2022

Flora Growth Corp. to Report Fiscal Year 2021 Results on May 10, 2022

Flora Growth Corp. Announces Launch of New Skincare Line Under Its Brand, MIND Naturals

High number of new and inexperienced directors

Flora Growth Corp. Appoints Jessie Casner as Chief Marketing Officer to Drive Growth of Brand Portfolio

Flora Growth Registers First-Ever Cannabinoid Food and Beverage Products with Colombian-FDA

Flora Growth Corp. Names Vessel Founder, James Choe, Chief Strategy Officer

Flora Growth Corp. Appoints Derek Pedro as an Advisor to its Cosechemos Cultivation Facility

Analyse de la situation financière